These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 6823504)

  • 1. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation and cancer risk: evidence from epidemiology.
    Ron E
    Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982.
    Preston DL; Kato H; Kopecky K; Fujita S
    Radiat Res; 1987 Jul; 111(1):151-78. PubMed ID: 3446217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced cancer and its modifying factor among A-bomb survivors.
    Kato H
    Princess Takamatsu Symp; 1987; 18():117-24. PubMed ID: 3506538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ; Hoel DG
    Radiat Res; 1992 May; 130(2):249-66. PubMed ID: 1574582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.